Literature DB >> 16021572

Histological characteristics of tumor cells and stromal cells in vessels and lymph nodes are important prognostic parameters of extrahepatic bile duct carcinoma: a prospective study.

Takahiro Hasebe1, Masaru Konishi, Motoki Iwasaki, Yasushi Endoh, Toshio Nakagohri, Shinichiroh Takahashi, Taira Kinoshita, Atsushi Ochiai.   

Abstract

Extrahepatic bile duct carcinomas (EHBDCs) consist of primary tumors, tumors in vessels, and tumors in lymph nodes. The purpose of this study was to prospectively investigate whether the histological characteristics of tumor cells and tumor stromal cells in vessels and lymph nodes were significantly associated with the outcomes of 60 EHBDC patients as compared with the histological characteristics of tumor cells and tumor stromal cells in primary tumors. Multivariate analyses, using the Cox proportional hazard regression model, showed that in EHBDCs without nodal metastasis, blood vessel tumor emboli with an angiomatous stroma significantly increased the hazard ratios (HRs) of tumor recurrence and death ( P < .05). In EHBDCs with nodal metastasis, the presence of tumor necrosis in the nodal tumors significantly increased the HRs of tumor recurrence and initial distant organ metastasis ( P < .05). In EHBDCs located in the distal to middle portion of the extrahepatic bile duct, blood vessel tumor emboli with an angiomatous stroma significantly increased the HRs of tumor recurrence, initial distant organ metastasis, and death ( P < .05). Severe nuclear atypia of the tumor cells in lymph vessels significantly increased the HRs of tumor recurrence and initial distant organ metastasis ( P < .05). In EHBDCs located in the hilar portion of the extrahepatic bile duct, the presence of nodal tumors with more than 4 mitotic figures significantly increased the HRs of tumor recurrence and initial distant organ metastasis ( P < .05). Several histological characteristics of tumor cells and tumor stromal cells in vessels and lymph nodes have significant effects on tumor progression of EHBDCs.

Entities:  

Mesh:

Year:  2005        PMID: 16021572     DOI: 10.1016/j.humpath.2005.04.004

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  4 in total

1.  Portal vein resection in surgery for cancer of biliary tract and pancreas: special reference to the relationship between the surgical outcome and site of primary tumor.

Authors:  Isao Kurosaki; Katsuyoshi Hatakeyama; Masahiro Minagawa; Daisuke Sato
Journal:  J Gastrointest Surg       Date:  2007-10-30       Impact factor: 3.452

2.  Contaminating cells alter gene signatures in whole organ versus laser capture microdissected tumors: a comparison of experimental breast cancers and their lymph node metastases.

Authors:  Joshua Chuck Harrell; Wendy W Dye; Djuana M E Harvell; Carol A Sartorius; Kathryn B Horwitz
Journal:  Clin Exp Metastasis       Date:  2007-10-12       Impact factor: 5.150

Review 3.  The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases.

Authors:  Shahid Hussain; Bo Peng; Mathew Cherian; Jonathan W Song; Dinesh K Ahirwar; Ramesh K Ganju
Journal:  Front Immunol       Date:  2020-12-22       Impact factor: 7.561

4.  Different role of MSLN and CA125 co-expression as a prognostic predictor between perihilar and distal bile duct carcinoma.

Authors:  Yasuhiro Takihata; Takahiro Einama; Kazuki Kobayashi; Takafumi Suzuki; Naoto Yonamine; Ibuki Fujinuma; Takazumi Tsunenari; Yoji Yamagishi; Toshimitsu Iwasaki; Yoichi Miyata; Eiji Shinto; Sho Ogata; Hironori Tsujimoto; Hideki Ueno; Yoji Kishi
Journal:  Oncol Lett       Date:  2021-03-23       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.